Form 3/A Scully Royalty Ltd. For: Mar 18 Filed by: Howe Alan B
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||||||
1. Name and Address of Reporting Person
*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 03/18/2026 |
3. Issuer Name
and
Ticker or Trading Symbol
Scully Royalty Ltd. [ SRL ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) 03/18/2026 |
||||||||||||||
6. Individual or Joint/Group Filing (Check
Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Explanation of Responses: |
| Remarks: |
| The Form 3 filed with the Securities and Exchange Commission by Alan Howe (the "Reporting Person") on March 18, 2026 was filed in error. The Reporting Person is not a director of the Issuer. The Reporting Person was nominated by MILFAM, LLC and certain affiliated shareholders ("MILFAM") to stand for election as a director at the Issuer's annual general meeting of shareholders, which was scheduled to be held on December 27, 2025 (the "2025 AGM"). Thereafter, the incumbent directors of the Issuer purported to postpone the 2025 AGM. MILFAM still attempted to proceed with the 2025 AGM on the basis that MILFAM considered the incumbent directors to not have the power to postpone the 2025 AGM but, in the absence of the incumbent directors at the 2025 AGM, this became the subject of litigation in the Grand Court of the Cayman Islands. At the conclusion of that litigation, the Court determined that the incumbent directors did not have the authority to postpone the 2025 AGM. The Court also determined that the incumbent directors had exclusive power to appoint a chairman of the meeting and, accordingly, the MILFAM proxyholders did not have the authority to do so and were unable to transact any business at the 2025 AGM. Therefore, there was a failure to appoint any directors, including the Reporting Person, and the incumbent directors remain in office until either their successors are elected or they otherwise cease to hold office. |
| /s/ Alan Howe | 07/08/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Altius Provides 2nd Quarter 2026 Project Generation Update
- Core Axis Introduces Science-Driven Supplement Protocol Developed Specifically for Hashimoto's Thyroiditis
- Faraday Future Highlights Its EAI Robotics at Maker Faire Meetups, Advancing EAI Robot Co-Creation and Developer Ecosystem Growth
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share